Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1006
Bhandari P, Patel NK, Bhutani KK. Synthesis of new heterocyclic lupeol derivatives as nitric oxide and pro-inflammatory cytokine inhibitors Bioorganic & Medicinal Chemistry Letters 2014, 24, 3596-3599.
1007
Bhandari P, Patel NK, Gangwal RP, Sangamwar AT, Bhutani KK. Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: Synthesis, biological evaluation and docking studies Bioorganic & Medicinal Chemistry Letters 2014, 24, 4114-4119.
1008
Bhatia S, Bharatam PV. Possibility of the existence of donor-acceptor interactions in bis(azole)amines: an electronic structure analysis Journal of Organic Chemistry 2014, 79, 4852-4862.
1009
Boradia VM, Malhotra H, Thakkar JS, Tillu VA, Vuppala B, Patil P, Sheokand N, Sharma P, Chauhan AS, Raje M and Raje CI. Mycobacterium tuberculosis acquires iron by cell surface sequestration and internalization of human holo-transferrin Nature Communications 2014, .
1010
Boradia VM, Raje M, Raje CI. Protein moonlighting in iron metabolism: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Biochemical Society Transactions 2014, 42, 1796-1801.
1011
Chandna N, Kapoor JK, Grover J, Bairwa K, Goyal V, Jachak SM. Pyrazolylbenzyltriazoles as cyclooxygenase inhibitors: Synthesis and biological evaluation as dual anti-inflammatory and antimicrobial agents New Journal of Chemistry 2014, 38, 3662-3672.
1012
Chaudhary RK, Kardani J, Singh K, Banerjee R and Roy I. Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington's Disease NeuroMolecular Medicine 2014, 16, 280-291.
1013
Chitkara D, Mittal A, Mahato RI, Kumar N. Core-shell nanoparticulate formulation of gemcitabine: lyophilization, stability studies, and in vivo evaluation Drug Delivery and Translational Research 2014, 4, 439-451.
1014
Choubey AK, Dora CP, Bhatt TD, Gill MS, Suresh S. Development and evaluation of PEGylated Enoxaparin: a novel approach for enhanced anti-Xa activity Bioorganic Chemistry 2014, 54, 6-1.
1015
Chouhan M, Senwar KR, Kumar K, Sharma R, Nair VA. Catalytic C-H activation of arylacetylenes: A fast assembly of 3-(arylethynyl)-3-hydroxyindolin-2-ones using CuI/DBU Synthesis 2014, 46, 195-202.
1016
Damre MV, Gangwal RP, Dhoke GV, Lalit M, Sharma D, Khandelwal K Sangamwar AT. 3D-QSAR and molecular docking studies of amino-pyrimidine derivatives as PknB inhibitors Journal of the Taiwan Institute of Chemical Engineers 2014, 45, 354-364.
1017
Dani P, Puri V, Bansal AK. Solubility advantage from amorphous etoricoxib solid dispersions Drug development and industrial pharmacy 2014, 40, 92-101.
1018
Dara A, Sangamwar AT. Clearing the fog of anticancer patents from 1993-2013: through an in-depth technology landscape & target analysis from pioneer research institutes and universities worldwide PLoS One 2014, 9, e103847.-.
1019
Dara A, Sangamwar AT. Identifying the patent trend, licensing pattern and geographical landscape analysis of the Council for Scientific & Industrial Research (CSIR) of India between 2000 and 2011 World Patent Information 2014, 38, 42-49.
1020
Das D, Preet R, Mohapatra P, Satapathy SR, Siddharth S, Tamir T, Jain V, Bharatam PV, Wyatt MD, Kundu CN. 5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway DNA Repair 2014, 24, 15-25.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|68|15